A NEW study shows a daily multivitamin may slow biological ageing, which reflects how old a body is in terms of health and ...

Epcoritamab plus R-DHAX/C achieved 79% ORR and 69% CR, with median 1.4 months to response and early activity evident by the ...

Dr Marc Laniado made a choice to be more mindful of his own health - here's what he discovered, from 'exercise snacking' to ...

Efficacy, safety, and cost-effectiveness of reduced vs. full initial dose androgen receptor signaling inhibitors in non-metastatic castration-resistant prostate cancer: A multicenter retrospective ...

Dynamic investigator initiated enterprise (DIVINE) in prostate cancer: Randomized phase II trial of stereotactic body radiotherapy with or without short-course androgen deprivation and AR pathway ...

Kirstyn Hill has worked as a clinical pediatric and women’s health pharmacist since 2020. She was driven to work with a patient population that is not often able to easily speak up for themselves and ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Men, take note. The natural formula combines 360 ...

WHIPPANY, N.J. - Bayer announced Thursday that final results from the Phase III PEACE-3 trial showed Xofigo (radium-223 dichloride) combined with enzalutamide reduced the risk of death by 24% compared ...

The PEACE-3 trial was an international, randomized, open-label study involving 446 patients with metastatic castration-resistant prostate cancer and at least two bone metastases. Patients were ...

Final results for the key secondary endpoint of overall survival (OS) from the PEACE-3 trial will be presented by the European Organization for Research and Treatment of Cancer (EORTC) coalition as an ...